Transmission intensity and drug resistance in malaria population dynamics: Implications for climate change

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Artzy Randrup, Yael ^a   Alonso, David ^b   Pascual, Mercedes ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CLIMATE CHANGE; DRUG TREATMENT FAILURE; GEOGRAPHIC DISTRIBUTION; HIGH TEMPERATURE; IMMUNE STATUS; INCIDENCE; KENYA; MALARIA FALCIPARUM; MICROBIAL POPULATION DYNAMICS; PARASITE TRANSMISSION; PARASITE VECTOR; TREND STUDY; UGANDA; AFRICA; DISEASE TRANSMISSION; HUMAN; MALARIA;

AFRICA, EASTERN; CLIMATE CHANGE; HUMANS; MALARIA;

EID: 78149417912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013588     Document Type: Article

References (60)

1. Klein E, Smith DL, Boni MF, Laxminarayan R (2008) Clinically immune hosts as a refuge for drug-sensitive malaria parasites. Malaria Journal 7(67).
2. Killeen GF, McKenzie FE, Foy BD, Schieffelin C, Billingsley PF, et al. (2000) A simplified model for predicting malaria entomologic inoculation rates based on entomologic and parasitologic parameters relevant to control. Am J Trop Med Hyg 62: 535-544.
3. MacDonald G (1957) The Epidemiology and Control of Malaria. London, United Kingdom: Oxford University Press.
4. Patz JA, Olson SH (2006) Malaria risk and temperature: Influences from global climate change and local land use practices. PNAS 103(15): 5635-5636.
5. Paaijmans KP, Read AF, Thomas MB (2009) Understanding the link between malaria risk and climate. PNAS 106(33): 13844-13849.
6. Hay S, Cox J, Rogers D, Randolph S, Stern D, et al. (2002) Climate change and the resurgence of malaria in the East African highlands. Nature 415: 905-909.
7. Shanks G, Hay S, Omumbo J, Snow R (2005) Malaria in Kenya's Western Highlands. Emerging Infectious Diseases 11(9).
8. Pascual M, Ahumada J, Chaves L, Rodó X, Bouma M (2006) Malaria resurgence in East African Highlands: temperature trends revisited. PNAS 103: 5829-5834.
9. Pascual M, Dobson A, Bouma M (2009) Underestimating malaria risk under variable temperatures. PNAS 106(33): 13645-13646.
10. Hastings I (1997) A model for the origins and spread of drug-resistant malaria. Parasitology 115 (Pt 2): 133-141.
11. Dye C, Williams B (1997) Multigenic drug resistance among inbred malaria parasites. Proc R Soc Lond B Biol Sci 264: 61-67.
12. Hastings I (2003) Malaria control and the evolution of drug resistance: an intriguing link. Trends in Parasitology 19: 70-73.
13. Hastings I, Watkins W (2005) Intensity of malaria transmission and the evolution of drug resistance. Acta Tropica 94: 218-229.
14. Pongtavornpinyo W, Yeung S, Hastings I, Dondrop A, Day N, et al. (2008) Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Malaria Journal 7: 229.
15. Koella J, Anita R (2003) Epidemiological models for the spread of anti-malarial resistance. Malaria Journal 2(3).
16. Read A, Huijben S (2009) Evolutionary biology and the avoidance of antimicrobial resistance. Evolutionary Applications. pp 40-51.
17. Patz J, Hulme M, Rosenzweig C, Mitchell T, Goldberg R, et al. (2002) Climate change (Communication arising): Regional warming and malaria resurgence. Nature 420: 627-628.
18. Pascual M, Bouma M (2009) Do rising temperatures matter? Ecology 90: 906-912.
19. Lafferty K (2009) Calling for an ecological approach to studying climate change and infectious diseases. Ecology 90(4): 932-933.
20. Masaba S, Anyona D, Chepkwoni D (1985) In vitro response of Plasmodium falciparum to chloroquine in the Nandi district, Kenya. Bull World Health Organ 63: 593-595.
21. Rapuoda B, Ouma J, Njiagi K, Khan B, Omar S (1996) Status of antimalarial drugs sensitivity in Kenya. Malaria and Infectious Diseases in Africa 8: 25-43.
22. Talisuna A, Okello P, Erhart A, Coosemans M, D'Alessandro U (2007) Intensity of Malaria Transmission and the Spread of Plasmodium falciparum-Resistant Malaria: A Review of Epidemiologic Field Evidence. Am J Trop Med Hyg 77: 170-180.
23. Talisuna A, Langi P, Bakyaita N, Egwang T, Mutabingwa T, et al. (2002) Intensity of malaria transmission, antimalarial drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg 96: 310-317.
24. Talisuna A, Langi P, Mutabingwa T, Van Marck E, Speybroeck N, et al. (2003) Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria. Int J Parasitol 33: 1051-1058.
25. Baird J (1995) Host Age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitology Today 11(3): 105-111.
26. Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, et al. (2005) Association of Transmission Intensity and Age With Clinical Manifestations and Case Fatality of Severe Plasmodium falciparum Malaria. JAMA 293: 1461-1470.
27. Snow R, Omumbo J, Lowe B, Molyneux C, Obiero J, et al. (1997) Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349(9066): 1650-1654.
28. Dietz K, Molineaux L, Thomas A (1974) A malaria model tested in the African savannah. Bull World Health Organ 50(3-4): 347-357.
29. Snow R, Marsh K (2002) The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 52: 235-264.
30. Smith T, Killeen G, Lengeler C, Tanner M (2004) Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. Am J Trop Med Hyg 71: 80-86.
31. Bonnet S, Gouagna L, Paul R, Safeukui I, Meunier J, et al. (2003) Estimation of malaria transmission from humans to mosquitoes in two neighbouring villages in south Cameroon: evaluation and comparison of several indices. Trans R Soc Trop Med Hyg 97(1): 53-59.
32. Githeko A, Brandling-Bennett A, Beier M, Atieli F, Owaga M, et al. (1992) The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg 86(4): 355-358.
33. Gouagna L, Ferguson H, Okech B, Killeen G, Kabiru E, et al. (2004) Plasmodium falciparum malaria disease manifestations in humans and transmission to Anopheles gambiae: a field study in Western Kenya. Parasitology 128: 235-243.
34. Trape J, Rogier C, Konate L, Diagne N, Bouganali H, et al. (1994) The Dielmo Project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51(2): 123-137.
35. Hastings I, Donnelly M (2005) The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist Updat 8(1-2): 43-50.
36. Hayward R, Saliba K, Kirk K. (2005) pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Molecular Microbiology 55(4): 1285-1295.
37. Laufer M, Plowe C (2004) Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies. Elsevier: Drug Resist Updat 7(4-5): 279-288.
38. White N (1998) Preventing antimalarial drug resistance through combinations. Drug Resist Updat 1(1): 3-9.
39. Gupta S, Trenhome K, Andeson R, Day K (1994) Antigenic diversity and the transmission dynamics of Plasmodium falciparum. Science 263: 961-963.
40. Barry A, Leliwa-Sytek A, Tavul L, Imrie H, Migot-Nabias F, et al. (2007) Population Genomics of the Immune Evasion (var) Genes of Plasmodium falciparum. PLoS Pathog 3(3): e34.
41. Alonso D, Bouma M, Pascual M. (2010) Epidemic malaria and warmer temperatures in recent decades in an East African highland. Under review for Proc R Soc Lond B Biol Sci.
42. Hay S, Noor A, Simba M, Busolo M, Guyatt H, et al. (2002) Clinical Epidemiology of Malaria in the Highlands of Western Kenya. Emerging Infectious Diseases 8(6).
43. Babiker H (2009) Seasonal fluctuation of drug-resistant malaria parasites: a sign of fitness cost. Trends in Parasitology 25(8).
44. Babiker H, Satti G, Ferguson H, Bayoumi R, Walliker D (2005) Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Tropica 94: 260-268.
45. Escalante A, Smith D, Kim Y (2009) The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum. Trends in Parasitology 25(12): 557-563.
46. White N, Pongtavornpinyo W (2003) The de novo selection of drug resistant malaria parasites. Proc R Soc Lond B 270(1514): 545-554.
47. Mharakurwa S, Mutambu S, Mudyiradima R, Chimbadzwa T, Chandiwana S, et al. (2004) Association of house spraying with suppressed levels of drug resistance in Zimbabwe. Malaria Journal 3: 35.
48. Hastings I, Mackinnon M (1998) The emergence of drug-resistant malaria. Parasitology 117(Pt. 5): 411-417.
49. Ariey F, Robert V (2003) The puzzling links between malaria transmission and drug resistance. Trends in Parasitology 19: 158-160.
50. Hastings I (2003) Response to: The puzzling links between malaria transmission level and drug resistance. Trends in Parasitology 19(4): 160-161.
51. Schmidt K (1995) Inbred parasites may spur resistance. Science 269: 1670.
52. Curtis C, Otoo L (1986) A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Trans R Soc Trop Med Hyg 80: 889-892.
53. Hastings I, D'Alessandro U (2000) Modelling a Predictable Disaster: The Rise and Spread of Drug-resistant Malaria. Parasitology Today 16(8).
54. Maire N, Smith T, Ross A, Owusu-Agyei S, Dietz K, et al. (2006) A model for natural immunity to asexual blood stages of plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg 75: 19-31.
55. Bekessy A, Molineaux L, Storey J (1976) Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull World Health Organ 54: 685-693.
56. Molineaux L, Gramiccia G (1980) Gramiccia, The Garki Project: Research on the epidemiology and control of malaria in the Sudan savanna of West Africa. Geneva: World Health Organization.
57. Gupta S, Day K (1994) A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria. Parasite Immunology 16: 361-370.
58. Smith T, Vounatsou P (2003) Estimation of infection and recovery rates for highly polymorphic parasites when detectability is imperfect, using hidden Markov models. Statistics in Medicine 22: 1709-1724.
59. Smith D, McKenzie F (2004) Statics and dynamics of malaria infection in Anopheles mosquitoes. Malaria Journal 3(13).
60. Aron L (1983) Dynamics of acquired immunity boosted by exposure to infection. Mathematical Biosciences. Mathematical Biosciences 64: 249-259.